Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Colorectal Neoplasms 2 Recurrence 1 Rectal Neoplasms 1 Neoplasms 1 Motor Activity 1 Lymphoma 1 Leukemia, B-Cell 1 Glioma 1 Glioblastoma 1 Colorectal Cancer Prevention 1 Colonic Neoplasms 1 Anastomotic Leak 1

Interventions

Cyclophosphamide 5 ibrutinib 4 fludarabine 4 pirtobrutinib 3 obinutuzumab 3 acalabrutinib 3 fludarabine phosphate 2 Rituximab 2 Mesna 2 venetoclax 1 ricolinostat 1 idelalisib 1 Whole-Body Irradiation 1 Vincristine 1 Tacrolimus 1 Stem Cell Transplantation 1 Prednisone 1 Peripheral Blood Stem Cell Transplantation 1 Patient Reported Outcome Measures 1 Mycophenolic Acid 1 Melphalan 1 Leukapheresis 1 Doxorubicin 1 Diet 1 Busulfan 1 Bone Marrow Transplantation 1 ARQ531 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia, B-Cell × Diet × 90 days × Clear all

NCT07487428 2026-03-23

CLL-IMPACT

Technical University of Munich

Phase NA Recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡